Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pamidronate for SAPHO Syndrome
NCT02544659Phase 1Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Oct 2015
- Primary completion
- Oct 2016
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, open-label, single-arm trial of pamidronate in SAPHO syndrome (SAPHO), sponsored by Peking Union Medical College Hospital. Primary endpoint: Response to treatment by change of MRI result at 6 months. Started Oct 2015; status: completed.
02
Drugs
pamidronate
03
Conditions
SAPHO syndrome (SAPHO)
Beyond the preview
Go deeper on NCT02544659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02544659.